Biogen Inc (BIIB) Rating Increased to Overweight at Piper Jaffray


In related news, CMO Alfred Sandrock sold 441 shares of the business's stock in a transaction that occurred on Friday, December 4th. The stock was sold at an average price of $277.00, for a total transaction of $122,157.00.



from Biotech News